Literature DB >> 12718937

CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes.

Roberto Lande1, Francesca Urbani, Beatrice Di Carlo, Giuseppe Sconocchia, Silvia Deaglio, Ada Funaro, Fabio Malavasi, Clara M Ausiello.   

Abstract

CD38 signaling, either induced by ligation with specific agonistic monoclonal antibody (mAb) or after interaction with CD31, its cognate counter-receptor, is involved in release of IL-1beta, IL-6, and IL-10 cytokines in resting human monocytes. CD38 ligation by the F(ab')(2) IB4 mAb did not induce signals relevant for cytokine secretion and the block of the Fcgamma receptor I (FcgammaRI) by anti-CD64 or FcgammaRII by anti-CD32 mAb did not inhibit CD38-mediated IL-1beta release. Dimerization or multimerization of the CD38 molecule by: (i) cross-linking of the receptor ligated by F(ab')(2) or by (ii) increasing CD38 expression by treating monocytes with IFNgamma were able to restore the truncated CD38-mediated signals involved in cytokine secretion. These data indicate that CD38 receptor-mediated signals operate directly suggesting a Fcgamma receptorial surface molecule independent activation pathway. The key element for the receptor mediated signaling is represented by surface density of CD38 on resting monocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12718937     DOI: 10.1016/s0008-8749(03)00025-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.

Authors:  Johanna Congleton; Miaoqing Shen; Robert MacDonald; Fabio Malavasi; Andrew Yen
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

2.  Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

Authors:  Sandra March; Mariona Graupera; María Rosa Sarrias; Francisco Lozano; Pilar Pizcueta; Jaume Bosch; Pablo Engel
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 3.  CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models.

Authors:  Alonso G P Guedes; Deepak A Deshpande; Mythili Dileepan; Timothy F Walseth; Reynold A Panettieri; Subbaya Subramanian; Mathur S Kannan
Journal:  Can J Physiol Pharmacol       Date:  2014-12-09       Impact factor: 2.273

4.  Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Sabrina B Mücklich; Ellen Leich; Manik Chatterjee; Sabine M Klauck; Thomas Efferth
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

5.  Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals.

Authors:  Dorothy Hudig; Kenneth W Hunter; W John Diamond; Doug Redelman
Journal:  Cytometry B Clin Cytom       Date:  2013-12-10       Impact factor: 3.058

6.  CD38 expression as response of hematopoietic system to cancer.

Authors:  Işil Albeniz; Ozlem Demir-Coşkun; Leyla Türker-Şener; Aycan Baş; Oktar Asoğlu; Rüstem Nurten
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

7.  Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium.

Authors:  Qun Liu; Richard Graeff; Irina A Kriksunov; Connie M C Lam; Hon Cheung Lee; Quan Hao
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

8.  CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.

Authors:  Roberto Arriga; Sara Caratelli; Giulia Lanzilli; Alessio Ottaviani; Carlo Cenciarelli; Tommaso Sconocchia; Giulio C Spagnoli; Giandomenica Iezzi; Mario Roselli; Davide Lauro; Andrea Coppola; Gianpietro Dotti; Soldano Ferrone; Giuseppe Sconocchia
Journal:  Int J Cancer       Date:  2019-08-30       Impact factor: 7.396

9.  In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.

Authors:  Sara Caratelli; Roberto Arriga; Tommaso Sconocchia; Alessio Ottaviani; Giulia Lanzilli; Donatella Pastore; Carlo Cenciarelli; Adriano Venditti; Maria Ilaria Del Principe; Davide Lauro; Elisa Landoni; Hongwei Du; Barbara Savoldo; Soldano Ferrone; Gianpietro Dotti; Giuseppe Sconocchia
Journal:  Int J Cancer       Date:  2019-10-12       Impact factor: 7.396

10.  Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.

Authors:  Alak Manna; Timothy Kellett; Sonikpreet Aulakh; Laura J Lewis-Tuffin; Navnita Dutta; Keith Knutson; Eduardo Chini; Javier Pinilla-Ibarz; Nicole Lamanna; Rami Manochakian; Fabio Malavasi; Taimur Sher; Asher A Chanan-Khan; Sikander Ailawadhi; Aneel Paulus
Journal:  Blood Adv       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.